The 6th Annual Liver Connect Meeting of the Chronic Liver Disease Foundation was held from February 26–28, 2026, at the Gaylord Pacific Resort & Convention Center in beautiful San Diego, California. The meeting brought together more than 500 in-person attendees, along with a substantial number of virtual participants from across the country and internationally.
The scientific program covered the full spectrum of chronic liver diseases, including metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction–associated alcohol-related liver disease (MetALD), alcohol-associated liver disease (ALD), cholestatic liver diseases, viral hepatitis, cirrhosis, and pediatric hepatology. Sessions were designed to address both cutting-edge scientific advances and their practical application in clinical practice.
Lectures were complemented by highly interactive discussions that engaged participants in thoughtful dialogue around emerging data, evolving therapeutic strategies, and implementation challenges. The meeting also provided valuable opportunities for collaboration and networking among attendees, distinguished faculty, and industry partners, further strengthening the shared commitment to advancing care for patients with chronic liver disease.
